Bupivacaine Liposomal versus Bupivacaine: Comparative Review

Authors

John Noviasky, Upstate University Hospital at Community General
Deirdre P. Pierce, St. John Fisher University
Karen M. Whalen, St. Joseph's Hospital Health Center
Roy Guharoy, University of Massachusetts Medical School
Kenneth Hildreth, Upstate University Hospital at Community General

Document Type

Article

Publication Date

6-1-2014

Abstract

Bupivacaine liposomal injection was recently approved by the US Food and Drug Administration (FDA) as a local anesthetic for use in management of postsurgical pain in adults. When compared to placebo, bupivacaine liposomal decreases postoperative pain and opioid use. This review examines the efficacy of bupivacaine liposomal when compared to conventional bupivacaine ± epinephrine using published and unpublished data provided to the FDA by the manufacturer.

DOI

https://doi.org/10.1310%2Fhpj4906-539

Publication Information

Noviasky, John; Pierce, Deirdre P.; Whalen, Karen M.; Guharoy, Roy; and Hildreth, Kenneth (2014). "Bupivacaine Liposomal versus Bupivacaine: Comparative Review." Hospital Pharmacy 49.6, 539-543.

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.